Hospital care and survival of acute myocardial infarction patients in Minnesota and Southern Germany: A comparative study

Eyal Shahar, Michael Lewis, Ulrich Keil, Paul G. McGovern, Hannelore Löwel, Russell V. Luepker

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: The hospital care of patients with acute myocardial infarction (AMI) is likely to vary among advanced industrialized countries, but only few studies have systematically documented such differences. Moreover, despite likely differences in medical care, it is not known whether the prognosis of AMI patients differs among countries. Methods: Using two registries of hospitalized AMI, we compared the characteristics, medical care, and survival through 1 year of patients in Augsburg, South Germany (n = 464) and Minneapolis-St Paul (the Twin Cities), Minnesota, USA (n = 504). The samples included patients aged 25-74 years who had been treated in a coronary care unit and survived the first 24 h after admission. Results: The two groups of patients did not differ in age distribution, sex ratio, or delay before admission to hospital (700% admitted within 6 h of symptom onset). The risk profile with respect to cardiovascular disease (smoking, hypertension, and diabetes) was more unfavourable among Augsburg patients than it was among Twin Cities patients but Twin Cities patients were more likely (P < 0.05) than Augsburg patients to report a previous myocardial infarction (29 versus 200%), coronary bypass surgery (9 versus 4%), and coronary angioplasty (6 versus 1%). Revascularization procedures were performed more frequently (P < 0.005) during the index hospitalization in the Twin Cities than they were in Augsburg: thrombolytic therapy 38 versus 28%, angioplasty 27 versus 130%, and bypass surgery 9 versus 3%. In contrast, cardiovascular medications, such as β-blockers and aspirin, were administered more frequently in Augsburg than they were in the Twin Cities. There were substantial differences in duration of hospital stay between the two sites with a median stay of 22 days for Augsburg patients versus 7 days for Twin Cities patients. However, there were no significant differences in 26-day case-fatality (6% in both) or 1-year survival (89% in Augsburg versus 88% in the Twin Cities, P = 0.70). Likewise, in multivariate analysis, allowing for the effects of age, sex and a history of myocardial infarction, the registry site was predictive neither of 28-day nor of 1-year mortality. Conclusion: These data document significant differences in the medical care of AMI patients in Minnesota and Augsburg, which, nonetheless, did not translate into survival differences.

Original languageEnglish (US)
Pages (from-to)467-473
Number of pages7
JournalCoronary Artery Disease
Volume7
Issue number6
StatePublished - 1996
Externally publishedYes

Fingerprint

Germany
Myocardial Infarction
Survival
Angioplasty
Registries
Coronary Care Units
Thrombolytic Therapy
Age Distribution
Sex Ratio
Developed Countries
Aspirin
Length of Stay
Patient Care
Hospitalization
Cardiovascular Diseases
Multivariate Analysis
Smoking
Hypertension
Mortality

Keywords

  • medical care
  • myocardial infarction
  • survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hospital care and survival of acute myocardial infarction patients in Minnesota and Southern Germany : A comparative study. / Shahar, Eyal; Lewis, Michael; Keil, Ulrich; McGovern, Paul G.; Löwel, Hannelore; Luepker, Russell V.

In: Coronary Artery Disease, Vol. 7, No. 6, 1996, p. 467-473.

Research output: Contribution to journalArticle

Shahar, Eyal ; Lewis, Michael ; Keil, Ulrich ; McGovern, Paul G. ; Löwel, Hannelore ; Luepker, Russell V. / Hospital care and survival of acute myocardial infarction patients in Minnesota and Southern Germany : A comparative study. In: Coronary Artery Disease. 1996 ; Vol. 7, No. 6. pp. 467-473.
@article{326a75790e9948f9a256eb156bdb5f9a,
title = "Hospital care and survival of acute myocardial infarction patients in Minnesota and Southern Germany: A comparative study",
abstract = "Background: The hospital care of patients with acute myocardial infarction (AMI) is likely to vary among advanced industrialized countries, but only few studies have systematically documented such differences. Moreover, despite likely differences in medical care, it is not known whether the prognosis of AMI patients differs among countries. Methods: Using two registries of hospitalized AMI, we compared the characteristics, medical care, and survival through 1 year of patients in Augsburg, South Germany (n = 464) and Minneapolis-St Paul (the Twin Cities), Minnesota, USA (n = 504). The samples included patients aged 25-74 years who had been treated in a coronary care unit and survived the first 24 h after admission. Results: The two groups of patients did not differ in age distribution, sex ratio, or delay before admission to hospital (700{\%} admitted within 6 h of symptom onset). The risk profile with respect to cardiovascular disease (smoking, hypertension, and diabetes) was more unfavourable among Augsburg patients than it was among Twin Cities patients but Twin Cities patients were more likely (P < 0.05) than Augsburg patients to report a previous myocardial infarction (29 versus 200{\%}), coronary bypass surgery (9 versus 4{\%}), and coronary angioplasty (6 versus 1{\%}). Revascularization procedures were performed more frequently (P < 0.005) during the index hospitalization in the Twin Cities than they were in Augsburg: thrombolytic therapy 38 versus 28{\%}, angioplasty 27 versus 130{\%}, and bypass surgery 9 versus 3{\%}. In contrast, cardiovascular medications, such as β-blockers and aspirin, were administered more frequently in Augsburg than they were in the Twin Cities. There were substantial differences in duration of hospital stay between the two sites with a median stay of 22 days for Augsburg patients versus 7 days for Twin Cities patients. However, there were no significant differences in 26-day case-fatality (6{\%} in both) or 1-year survival (89{\%} in Augsburg versus 88{\%} in the Twin Cities, P = 0.70). Likewise, in multivariate analysis, allowing for the effects of age, sex and a history of myocardial infarction, the registry site was predictive neither of 28-day nor of 1-year mortality. Conclusion: These data document significant differences in the medical care of AMI patients in Minnesota and Augsburg, which, nonetheless, did not translate into survival differences.",
keywords = "medical care, myocardial infarction, survival",
author = "Eyal Shahar and Michael Lewis and Ulrich Keil and McGovern, {Paul G.} and Hannelore L{\"o}wel and Luepker, {Russell V.}",
year = "1996",
language = "English (US)",
volume = "7",
pages = "467--473",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Hospital care and survival of acute myocardial infarction patients in Minnesota and Southern Germany

T2 - A comparative study

AU - Shahar, Eyal

AU - Lewis, Michael

AU - Keil, Ulrich

AU - McGovern, Paul G.

AU - Löwel, Hannelore

AU - Luepker, Russell V.

PY - 1996

Y1 - 1996

N2 - Background: The hospital care of patients with acute myocardial infarction (AMI) is likely to vary among advanced industrialized countries, but only few studies have systematically documented such differences. Moreover, despite likely differences in medical care, it is not known whether the prognosis of AMI patients differs among countries. Methods: Using two registries of hospitalized AMI, we compared the characteristics, medical care, and survival through 1 year of patients in Augsburg, South Germany (n = 464) and Minneapolis-St Paul (the Twin Cities), Minnesota, USA (n = 504). The samples included patients aged 25-74 years who had been treated in a coronary care unit and survived the first 24 h after admission. Results: The two groups of patients did not differ in age distribution, sex ratio, or delay before admission to hospital (700% admitted within 6 h of symptom onset). The risk profile with respect to cardiovascular disease (smoking, hypertension, and diabetes) was more unfavourable among Augsburg patients than it was among Twin Cities patients but Twin Cities patients were more likely (P < 0.05) than Augsburg patients to report a previous myocardial infarction (29 versus 200%), coronary bypass surgery (9 versus 4%), and coronary angioplasty (6 versus 1%). Revascularization procedures were performed more frequently (P < 0.005) during the index hospitalization in the Twin Cities than they were in Augsburg: thrombolytic therapy 38 versus 28%, angioplasty 27 versus 130%, and bypass surgery 9 versus 3%. In contrast, cardiovascular medications, such as β-blockers and aspirin, were administered more frequently in Augsburg than they were in the Twin Cities. There were substantial differences in duration of hospital stay between the two sites with a median stay of 22 days for Augsburg patients versus 7 days for Twin Cities patients. However, there were no significant differences in 26-day case-fatality (6% in both) or 1-year survival (89% in Augsburg versus 88% in the Twin Cities, P = 0.70). Likewise, in multivariate analysis, allowing for the effects of age, sex and a history of myocardial infarction, the registry site was predictive neither of 28-day nor of 1-year mortality. Conclusion: These data document significant differences in the medical care of AMI patients in Minnesota and Augsburg, which, nonetheless, did not translate into survival differences.

AB - Background: The hospital care of patients with acute myocardial infarction (AMI) is likely to vary among advanced industrialized countries, but only few studies have systematically documented such differences. Moreover, despite likely differences in medical care, it is not known whether the prognosis of AMI patients differs among countries. Methods: Using two registries of hospitalized AMI, we compared the characteristics, medical care, and survival through 1 year of patients in Augsburg, South Germany (n = 464) and Minneapolis-St Paul (the Twin Cities), Minnesota, USA (n = 504). The samples included patients aged 25-74 years who had been treated in a coronary care unit and survived the first 24 h after admission. Results: The two groups of patients did not differ in age distribution, sex ratio, or delay before admission to hospital (700% admitted within 6 h of symptom onset). The risk profile with respect to cardiovascular disease (smoking, hypertension, and diabetes) was more unfavourable among Augsburg patients than it was among Twin Cities patients but Twin Cities patients were more likely (P < 0.05) than Augsburg patients to report a previous myocardial infarction (29 versus 200%), coronary bypass surgery (9 versus 4%), and coronary angioplasty (6 versus 1%). Revascularization procedures were performed more frequently (P < 0.005) during the index hospitalization in the Twin Cities than they were in Augsburg: thrombolytic therapy 38 versus 28%, angioplasty 27 versus 130%, and bypass surgery 9 versus 3%. In contrast, cardiovascular medications, such as β-blockers and aspirin, were administered more frequently in Augsburg than they were in the Twin Cities. There were substantial differences in duration of hospital stay between the two sites with a median stay of 22 days for Augsburg patients versus 7 days for Twin Cities patients. However, there were no significant differences in 26-day case-fatality (6% in both) or 1-year survival (89% in Augsburg versus 88% in the Twin Cities, P = 0.70). Likewise, in multivariate analysis, allowing for the effects of age, sex and a history of myocardial infarction, the registry site was predictive neither of 28-day nor of 1-year mortality. Conclusion: These data document significant differences in the medical care of AMI patients in Minnesota and Augsburg, which, nonetheless, did not translate into survival differences.

KW - medical care

KW - myocardial infarction

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=0029782457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029782457&partnerID=8YFLogxK

M3 - Article

C2 - 8889363

AN - SCOPUS:0029782457

VL - 7

SP - 467

EP - 473

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 6

ER -